Literature DB >> 17261750

Clinical correlates of circulating visfatin levels in a community-based sample.

Erik Ingelsson1, Martin G Larson, Caroline S Fox, Xiaoyan Yin, Thomas J Wang, Izabella Lipinska, Karla M Pou, Udo Hoffmann, Emelia J Benjamin, John F Keaney, Ramachandran S Vasan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17261750     DOI： 10.2337/dc06-2353

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  15 in total

1.  Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans.

Authors:  Eun Seok Kang; Faidon Magkos; Elizabeth Sienkiewicz; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2011-03-21       Impact factor: 6.664

2.  Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.

Authors:  M Ozkaya; M Sahin; E Cakal; F Yuzbasioglu; K Sezer; M Kilinc; S Simsek Imrek
Journal:  J Endocrinol Invest       Date:  2009-05-15       Impact factor: 4.256

3.  Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.

Authors:  C P Chung; A G Long; J F Solus; Y H Rho; A Oeser; P Raggi; C Michael Stein
Journal:  Lupus       Date:  2009-08       Impact factor: 2.911

Review 4.  The link between abdominal obesity and the metabolic syndrome.

Authors:  Liza K Phillips; Johannes B Prins
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

5.  Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome.

Authors:  Georgia Trakada; Paschalis Steiropoulos; Evangelia Nena; Theodora Gkioka; Georgios Kouliatsis; Athanasia Pataka; Ioannis Sotiriou; Stavros Anevlavis; Nikolaos Papanas; Demosthenes Bouros
Journal:  Sleep Breath       Date:  2009-04-10       Impact factor: 2.816

6.  Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans.

Authors:  D Friebe; M Neef; J Kratzsch; S Erbs; K Dittrich; A Garten; S Petzold-Quinque; S Blüher; T Reinehr; M Stumvoll; M Blüher; W Kiess; A Körner
Journal:  Diabetologia       Date:  2011-02-06       Impact factor: 10.122

7.  Epidemiology of micro- and macrovascular complications of type 2 diabetes in Korea.

Authors:  Jung Hee Kim; Dae Jung Kim; Hak Chul Jang; Sung Hee Choi
Journal:  Diabetes Metab J       Date:  2011-12-26       Impact factor: 5.376

Review 8.  Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome.

Authors:  Ewa Haładyj; Agnieszka Paradowska-Gorycka; Anna Felis-Giemza; Marzena Olesińska
Journal:  Reumatologia       Date:  2016-10-05

9.  Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans.

Authors:  Manfred Hallschmid; Harpal Randeva; Bee K Tan; Werner Kern; Hendrik Lehnert
Journal:  Diabetes       Date:  2008-12-18       Impact factor: 9.461

10.  NAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance.

Authors:  Shengbing Li; Cong Wang; Ke Li; Ling Li; Mingyuan Tian; Jing Xie; Mengliu Yang; Yanjun Jia; Junying He; Lin Gao; Guenther Boden; Hua Liu; Gangyi Yang
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.